Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New app aims to help women battling opioid addiction and abuse

NCT ID NCT07665502

Disease control Sponsor: Dawn A. Goddard-Eckrich Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 29, 2026 · Updated 4 times

Summary

This early study tests a mobile health program called WINGS+++ for women who use opioids and have experienced intimate partner violence. The program includes three sessions on a tablet or smartphone with videos, exercises, and a peer navigator to help connect to services. Researchers will check if it reduces drug use and helps women get treatment for substance use, trauma, and violence.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
WINGS+++ mobile health program (behavioral intervention)
What this could lead to
If successful, this could point toward a scalable way to help women with opioid use disorder and trauma get connected to treatment and reduce drug use.
What could go wrong
This is a very early pre-pilot with only 7 participants, so results may not apply broadly. The program may not effectively reduce drug use or link women to services.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 7 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Identify as a woman (cisgender or transgender) * Aged 18 or older * Report use of non-prescribed opioids in the past 30 days * Score positive for risk of opioid use disorder or other substance use disorder on the Drug Abuse Screening Test (DAST) with a cut-off score of 6 or higher * Report experiencing any severe psychological abuse or any physical or sexual abuse by a female or male intimate partner in the past year. Exclusion Criteria: * Evidence of significant psychiatric or cognitive impairment that would limit effective participation, as confirmed during informed consent; * Inability to speak and understand English sufficiently to participate in assessments or intervention sessions.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Domestic violence are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

combat disorder opiate dependence post-traumatic stress disorder substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Domestic violence Intimate partner violence (IPV) Medication for opioid use disorder (MOUD) Opioid-related disorders Post-traumatic stress disorder (PTSD) Stress disorders, post-traumatic Substance-related disorders

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Columbia University School of Social Work

    New York, New York, 10027, United States

  • Cornerstone

    Newburgh, New York, 12550, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.